![](https://dbtnews.com/wp-content/uploads/2020/01/Image-33.png)
why Iovance Biotherapeutics Inc [IOVA] is a Good Choice for Investors After New Price Target of $26.00
Iovance Biotherapeutics Inc [NASDAQ: IOVA] loss -18.48% on the last trading session, reaching $10.97 price per share at the time. If compared to the average trading volume of 8.84M shares, IOVA reached a trading volume of 19129266 in the most recent trading day, which is